Press Releases

The Global Digital Therapeutics Market size was valued at USD 457 billion in 2023. It is likely to grow up to USD 720 billion by 2030 at a CAGR of 5.7% during the forecast period ranging between 2025 and 2030.

Digital therapeutics are useful in diseases like diabetes, depression, sleep disorders and obesity. They help in reducing treatment costs and teach self-health management. these also facilitate real-time connection with doctors with an emphasis on improving lifestyle without medicines. The primary growth driver of the market is the development of telemedicine and mobile health applications. The increasing use of telemedicine and mobile apps has made the use of digital therapeutics easier and more widespread. However, getting government and health regulatory approval for digital therapeutics products is hindering the market growth.

Browse market data Tables and Figures spread through 140 Pages and in-depth TOC on Global Digital Therapeutics Market By Type (Software-Based, Device-Based and Cloud-Based Therapies), By Application (Mental Health, Physical Health and Lifestyle Management), By End User (Individual Patients, Healthcare Professionals and Insurance Companies), By Delivery Mode (Mobile Apps, Web Platforms and Cloud-Based Services) and By Geography (North America, Europe, Asia Pacific, Rest of the World) - Forecast from 2025 to 2030.

Global Digital Therapeutics Market Segmentation and Key Players

By type, software-based digital therapeutics dominated the global digital therapeutics market 

Software-based digital therapeutics is growing fastest as it provides personalized and affordable treatment to the patient at home.

"North America dominates the global digital therapeutics market." 

North America is leading the global digital therapeutics market due to greater digital health innovation and regulatory approvals. 

Some of the major players in this market are Omada Health, Teladoc Health Inc., Pear Therapeutics Inc., Kaia Health, Akili Interactive Labs Inc., Click Therapeutics Inc., Biofourmis, Welldoc Inc., Happify Health, 2Morrow Inc., Big Health Inc., Noom Inc., ResMed Inc., Medtronic, Voluntis Inc., Livongo Health Inc.

Recent Developments By the Key Players

CopilotIQ and Biofourmis collaborated to create the industry's first AI-driven platform that delivers in-home care across the full spectrum from pre-surgical optimization to acute, post-acute, and chronic care.

Click Therapeutics, Inc. has launched Software-Enhanced Drug therapies to pioneer a new prescription digital therapeutic product category in response to increasing interest in U.S. 

Global Digital Therapeutics Market  coverage (By Value)

•  Type Insight and Forecast 2025 - 2030
  • Software-Based
  • Device-Based
  • Cloud-Based Therapies
• Application Insight and Forecast 2025 - 2030
  • Mental Health
  • Physical Health
  • Lifestyle Management

• End User Insight and Forecast 2025 - 2030
  • Individual Patients
  • Healthcare Professionals
  • Insurance Companies
• Delivery Mode Insight and Forecast 2025 - 2030
  • Mobile Apps
  • Web Platforms
  • Cloud-Based Services

Geographical Segmentation

Global Digital Therapeutics Market by Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Vietnam
  • Thailand
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries